A unified meta-regression model identifies genes associated with epilepsy

Area of Science:

• Genetics
• Computational Biology
• Genomic Medicine

Background:

• Epilepsy is a complex neurological disorder with significant genetic underpinnings.
• Identifying rare genetic variants associated with epilepsy requires large sample sizes and high-quality data.
• Existing methods face challenges in accurately pinpointing epilepsy-associated genes due to data heterogeneity.

Purpose of the Study:

• To develop and validate a novel computational approach for predicting genomic constraint.
• To integrate multiple data sources for enhanced identification of epilepsy-associated genes.
• To strengthen evidence for known epilepsy genes and discover novel ones.

Main Methods:

• Applied a Hidden Markov Model (HMM) to whole exome sequencing (WES) data to predict genomic constraint.
• Utilized large-scale datasets: Regeneron Genetics Center Million Exome and AllofUs whole genome sequencing data.
• Integrated genomic constraint predictions with GERP RS scores, AlphaMissense (AM) pathogenicity, and Epi25 annotations into a unified model.

Main Results:

• Identified a set of significant epilepsy-associated genes (p < 3.4 × 10^-7), including novel candidates like KCNQ2, SCN2A, STXBP1, CACNA1A, SLC6A1, DYRK1A, KCNB1, SATB1, PCDHAC2, SP4, and RYR2.
• Demonstrated the model's ability to jointly evaluate genomic constraint, AlphaMissense pathogenicity, and predicted loss-of-function variants.
• Successfully strengthened evidence for previously known epilepsy genes and identified new potential disease-linked genes.

Conclusions:

• The developed computational framework effectively integrates diverse genomic data for robust epilepsy gene discovery.
• This approach enhances the power to detect genetic associations for complex disorders like epilepsy.
• The findings pave the way for improved genetic diagnostics and therapeutic strategies for epilepsy.